![]() AIkido Pharma AIkido Pharma (formerly known as Spherix) is a biotechnology company engaged in the development of small-molecule anti-cancer therapeutics. | ![]() Envisagenics Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies. | Syndivia Syndivia is a biotechnology company that develops treatment solutions to cancer patients by leveraging microenvironment and anatomical hallmarks for tumors. | |||
Founding Date | Founding Date 2022 | Founding Date 1967 | Founding Date 2014 | Founding Date 2014 | Founding Date 2014 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Bethesda, US HQ New York, US | Locations New York, US HQ New York, US | Locations Illkirch-Graffenstaden, FR HQ Strasbourg, FR | Locations Paris, FR HQ |
Employees | Employees 379% increase | Employees 350% decrease | Employees 548% increase | Employees 6 | Employees 12 |
Funding | |||||
Latest funding round | Latest funding round $ 14m (over 2 years ago) | Latest funding round N/A | Latest funding round $ 2.4m (over 8 years ago) | Latest funding round $ 2.3m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 14m | Total funding raised $ 27.2m | Total funding raised $ 3.1m | Total funding raised $ 3.9m | Total funding raised N/A |

AIkido Pharma (formerly known as Spherix) is a biotechnology company engaged in the development of small-molecule anti-cancer therapeutics.
View company
Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies.
View companySyndivia is a biotechnology company that develops treatment solutions to cancer patients by leveraging microenvironment and anatomical hallmarks for tumors.
View company
Feroscan is a company specializing in the development of personalized cytotoxics.
View company